Correlation Between Regenxbio and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Keros Therapeutics, you can compare the effects of market volatilities on Regenxbio and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Keros Therapeutics.
Diversification Opportunities for Regenxbio and Keros Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Regenxbio and Keros is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Regenxbio i.e., Regenxbio and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Regenxbio and Keros Therapeutics
Given the investment horizon of 90 days Regenxbio is expected to generate 1.98 times more return on investment than Keros Therapeutics. However, Regenxbio is 1.98 times more volatile than Keros Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Keros Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 859.00 in Regenxbio on September 1, 2024 and sell it today you would earn a total of 133.00 from holding Regenxbio or generate 15.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regenxbio vs. Keros Therapeutics
Performance |
| Timeline |
| Regenxbio |
| Keros Therapeutics |
Regenxbio and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regenxbio and Keros Therapeutics
The main advantage of trading using opposite Regenxbio and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |